| |
| |
| |
| A Nurse's Perspective of Pharmacology | |
| |
| |
| Drug Action: Pharmaceutic, Pharmacokinetic, and Pharmacodynamic Phases | |
| |
| |
| Nursing Process and Client Teaching | |
| |
| |
| Medication Safety NEW! | |
| |
| |
| Medication Administration | |
| |
| |
| |
| Drug Calculations | |
| |
| |
| Medications and Calculations | |
| |
| |
| |
| Systems of Measurement with Conversion | |
| |
| |
| |
| Methods for Calculation | |
| |
| |
| |
| Calculations of Oral Dosages | |
| |
| |
| |
| Calculations of Injectable Dosages | |
| |
| |
| |
| Calculations of Intravenous Fluids | |
| |
| |
| |
| Pediatric Drug Calculations | |
| |
| |
| |
| Contemporary Issues in Pharmacology | |
| |
| |
| The Drug Approval Process | |
| |
| |
| Cultural and Pharmacogenetic Considerations | |
| |
| |
| Drug Interaction and Over-the-Counter Drugs | |
| |
| |
| Drugs of Abuse | |
| |
| |
| Herbal Therapy with Nursing Implications | |
| |
| |
| Pediatric Pharmacology | |
| |
| |
| Geriatric Pharmacology | |
| |
| |
| Medication Administration in Community Settings | |
| |
| |
| The Role of the Nurse in Drug Research | |
| |
| |
| |
| Nutrition and Electrolytes | |
| |
| |
| Vitamin and Mineral Replacement | |
| |
| |
| Fluid and Electrolyte Replacement | |
| |
| |
| Nutritional Support | |
| |
| |
| |
| Autonomic Nervous System Agents | |
| |
| |
| Adrenergic Agonists and Adrenergic Blockers | |
| |
| |
| Cholinergic Agonists and Anticholinergics | |
| |
| |
| |
| Neurologic and Neuromuscular Agents | |
| |
| |
| Central Nervous System Stimulants | |
| |
| |
| Central Nervous System Depressants | |
| |
| |
| Anticonvulsants | |
| |
| |
| Drugs for Neurological Disorders: Parkinsonism and Alzheimer's Disease | |
| |
| |
| Drugs for Neuromuscular Disorders: Myasthenia Gravis, Multiple Sclerosis, and Muscle Spasms | |
| |
| |
| |
| Pain and Inflammation Management Agents | |
| |
| |
| Antiinflammatory Drugs | |
| |
| |
| Nonopioid and Opioid Analgesics | |
| |
| |
| |
| Psychiatric Agents | |
| |
| |
| Antipsychotics and Anxiolytics | |
| |
| |
| Antidepressants and Mood Stabilizers | |
| |
| |
| |
| Antibacterial Agents | |
| |
| |
| Penicillins and Cephalosporins | |
| |
| |
| Macrolides, Tetracyclines, Aminoglycosides, and Fluoroquinolones | |
| |
| |
| Sulfonamides | |
| |
| |
| |
| Antiinfective Agents | |
| |
| |
| Antituberculars, Antifungals, Peptides, and Metronidazole | |
| |
| |
| Antivirals, Antimalarials, and Anthelmintics | |
| |
| |
| Drugs for Urinary Tract Disorders | |
| |
| |
| |
| Immunologic Agents | |
| |
| |
| HIV- and AIDS-Related Drugs | |
| |
| |
| Vaccines | |
| |
| |
| |
| Antineoplastic Agents | |
| |
| |
| Anticancer Drugs | |
| |
| |
| Targeted Therapies to Treat Cancer | |
| |
| |
| Biologic Response Modifiers | |
| |
| |
| |
| Respiratory Agents | |
| |
| |
| Drugs for Upper Respiratory Disorders | |
| |
| |
| Drugs for Lower Respiratory Disorders | |
| |
| |
| |
| Cardiovascular Agents | |
| |
| |
| Cardiac Glycosides, Antianginals, and Antidysrhythmics | |
| |
| |
| Diuretics | |
| |
| |
| Antihypertensives | |
| |
| |
| Anticoagulants, Antiplatelets, and Thrombolytics | |
| |
| |
| Antihyperlipidemics and Peripheral Vasodilators | |
| |
| |
| |
| Gastrointestinal Agents | |
| |
| |
| Drugs for Gastrointestinal Tract Disorders | |
| |
| |
| Antiulcer Drugs | |
| |
| |
| |
| Eye, Ear, and Skin Agents | |
| |
| |
| Drugs for Eye and Ear Disorders | |
| |
| |
| Drugs for Dermatologic Disorders | |
| |
| |
| |
| Endocrine Agents | |
| |
| |
| Endocrine Drugs: Pituitary, Thyroid, Parathyroid, and Adrenal Disorders | |
| |
| |
| Antidiabetics | |
| |
| |
| |
| Reproductive and Gender-Related Agents | |
| |
| |
| Female Reproductive Cycle I: Pregnancy and Preterm Labor Drugs | |
| |
| |
| Female Reproductive Cycle II: Labor, Delivery, and Preterm Neonatal Drugs | |
| |
| |
| Postpartum and Newborn Drugs | |
| |
| |
| Drugs for Women's Reproductive Health and Menopause | |
| |
| |
| Drugs for Men's Health and Reproductive Disorders | |
| |
| |
| Drugs for Disorders in Women's Health, Infertility, and Sexually Transmitted Infections | |
| |
| |
| |
| Emergency Agents | |
| |
| |
| Adult and Pediatric Emergency Drugs | |
| |
| |
| Appendices | |
| |
| |
| |
| Therapeutic Drug Monitoring (TDM) | |
| |
| |
| |
| Potential Weapons of Bioterrorism | |